NCT02992925View on ClinicalTrials.gov

Phase 3 Study of BK1310 in Healthy Infants

PHASE3CompletedINTERVENTIONAL
Enrollment

370

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

November 30, 2018

Conditions
Immunization; Infection
Interventions
BIOLOGICAL

DPT-IPV-Hib-High（Combined Vaccine）

BIOLOGICAL

DPT-IPV-Hib-Low（Combined Vaccine）

BIOLOGICAL

Hib vaccine

BIOLOGICAL

DPT-IPV

Trial Locations (3)

Unknown

Fukuoka

Kasuga-shi

Sendai

Sponsors
All Listed Sponsors
collaborator

The Research Foundation for Microbial Diseases of Osaka University

OTHER

lead

Mitsubishi Tanabe Pharma Corporation

INDUSTRY